Levamlodipine Besylate

苯磺酸左旋氨氯地平

Report date: 2024/02/29 15:23:04

Base Information

Drug NameLevamlodipine Besylate
Drug Alias Name苯磺酸左氨氯地平Levotension
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsEssential HypertensionHypertensionAngina Pectoris
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritorySouth Korea
Original Approved Date2006/01/01
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAhn-Gook
China Registration ClassN/A

Develop Information

Active CompaniesAhn-GookCspc Ouyi Pharmaceutical Co LtdShihuida Pharmaceutical Group (Jilin) ​​Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC08CA01
Related LinksWikipediaDrugBank